Adaptimmune Therapeutics Plc Stock Performance
as on October 27, 2025 at 8:02 pm IST
- $0.07$0.07
52 Week's Low
52 Week's High
$0.04$0.86
42.43%
Downside
1128.57%
Upside
Adaptimmune Therapeutics Plc share price movements today
- Previous Close
- $0.06
- Open
- $0.07
- Volume
- 10.5M
- Day's Low - High
- $0.07 - $0.07
- 52 Week Low - High
- $0.04 - $0.86
Adaptimmune Therapeutics Plc Historical Returns
- 1 Month Return
- -55.99 %
- 3 Month Return
- -81.35 %
- 1 Year Return
- -91.23 %
- 3 Year Return
- -95.28 %
- 5 Year Return
- -98.65 %
Adaptimmune Therapeutics Plc Stock Fundamentals & Key Indicators
Check Adaptimmune Therapeutics Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$17.1M
EPS (TTM)
-0.471
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0.11
EBITDA
-137.2M
Revenue (TTM)
65.1M
Profit Margin
-260.82%
Return On Equity TTM
-1341.10%
Adaptimmune Therapeutics Plc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Adaptimmune Therapeutics Plc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $17.1M | -98.65% | NA | -260.82% | |
| BUY | $60.7B | 265.42% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $108.0B | 98.59% | 29.95 | 31.86% | |
| BUY | $61.3B | -0.78% | 14.55 | 31.37% |
Stock Returns calculator for Adaptimmune Therapeutics Plc Stock including INR - Dollar returns
The Adaptimmune Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Adaptimmune Therapeutics Plc investment value today
Current value as on today
₹14,534
Returns
Returns from Adaptimmune Therapeutics Plc Stock
Dollar Returns*
₹5,074 (+5.07%)
Analyst Recommendation on Adaptimmune Therapeutics Plc Stock
Based on 13 analysts
69.23%
Buy
23.08%
Hold
7.69%
Sell
Based on 13 analysts, 69.23% of analysts recommend a 'BUY' rating for Adaptimmune Therapeutics Plc. Average target price of $0.68
Adaptimmune Therapeutics Plc Share Price Target
Get share price movements and forecasts by analysts on Adaptimmune Therapeutics Plc.
What analysts predicted
89.71%UPSIDE
Target Price
$0.68
Current Price
$0.07
Analyzed by
13 Analysts
Target
$0.68
Adaptimmune Therapeutics Plc target price $0.68, a slight upside of 89.71% compared to current price of $0.07. According to 13 analysts rating.
Adaptimmune Therapeutics Plc Stock’s Investor Sentiment and Interest
Investment in Adaptimmune Therapeutics Plc Shares on INDmoney has grown by 29.33% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:29.33% versus previous 30 day period
Search interest for Adaptimmune Therapeutics Plc Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:22% versus previous 30 day period
Adaptimmune Therapeutics Plc Quarterly Profit & Loss
All numbers in Millions USD
Adaptimmune Therapeutics Plc Annual Profit & Loss
All numbers in Millions USD
Adaptimmune Therapeutics Plc Quarterly Cash Flow
All numbers in Millions USD
Adaptimmune Therapeutics Plc Annual Cash Flow
All numbers in Millions USD
Insights on Adaptimmune Therapeutics Plc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 3.22M → 13.67M (in $), with an average increase of 51.3% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, ADAP stock has moved up by 9.7%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -74.21M → -30.34M (in $), with an average increase of 56.4% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.9% return, outperforming this stock by 234.2%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 153.9%
About Adaptimmune Therapeutics Plc
| Organisation | Adaptimmune Therapeutics Plc |
| Headquarters | 60 Jubilee Avenue, Abingdon, United Kingdom, OX14 4RX |
| Industry | Health Technology |
| CEO | Mr. Adrian G. Rawcliffe |
| E-voting on shares | Click here to vote |
Key Management of Adaptimmune Therapeutics Plc
Name | Title |
|---|---|
Dr. Helen Katrina Tayton-Martin MBA, Ph.D. | Co-Founder |
Ms. Kerry Sharp | Senior VP & General Counsel |
Ms. Dana Lynch | Senior Director of Corporate Communications |
Ms. Kimberly Freeman | Vice President of Commercial Planning |
Laura Gunn | Vice President of Medical Affairs |
Mr. Adrian G. Rawcliffe | CEO & Director |
Mr. William Charles A. Bertrand Jr., Esq., J.D. | COO, Chief Compliance Officer & Secretary |
Mr. Christopher James Hill ACA, BA (Hons) | Chief Financial Officer |
Dr. Juli P. Miller Ph.D. | VP of Corporate Affairs & Investor Relations |
FAQs
What is Adaptimmune Therapeutics Plc share price today?
Adaptimmune Therapeutics Plc share price today is $0.07 as on . Adaptimmune Therapeutics Plc share today touched a day high of $0.07 and a low of $0.07.
What is the 52 week high and 52 week low for Adaptimmune Therapeutics Plc share?
Adaptimmune Therapeutics Plc share touched a 52 week high of $0.86 on and a 52 week low of $0.04 on . Adaptimmune Therapeutics Plc stock price today i.e. is trending at $0.07,which is 91.86% down from its 52 week high and 73.70% up from its 52 week low.
What is Adaptimmune Therapeutics Plc's market capitalisation today?
Adaptimmune Therapeutics Plc market capitalisation is $0.00T as on .
How to invest in Adaptimmune Therapeutics Plc Stock (ADAP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Adaptimmune Therapeutics Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adaptimmune Therapeutics Plc Shares that will get you 21.4286 shares as per Adaptimmune Therapeutics Plc share price of $0.07 per share as on October 27, 2025 at 8:02 pm IST.
What is the minimum amount required to buy Adaptimmune Therapeutics Plc Stock (ADAP) from India?
Indian investors can start investing in Adaptimmune Therapeutics Plc (ADAP) shares with as little as ₹88.189 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.89 in Adaptimmune Therapeutics Plc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Adaptimmune Therapeutics Plc share’s latest price of $0.07 as on October 27, 2025 at 8:02 pm IST, you will get 142.8571 shares of Adaptimmune Therapeutics Plc. Learn more about
fractional shares .
What are the returns that Adaptimmune Therapeutics Plc has given to Indian investors in the last 5 years?
Adaptimmune Therapeutics Plc stock has given -98.65% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?